- Home
- EDU vs BIRK Comparison
EDU vs BIRK Comparison
Compare EDU & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDU | BIRK |
|---|---|---|
| Founded | 1993 | 1774 |
| Country | China | United Kingdom |
| Employees | 84111 | N/A |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.0B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | EDU | BIRK |
|---|---|---|
| Price | $53.85 | $36.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $62.80 | $62.69 |
| AVG Volume (30 Days) | 645.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.75 | $13.71 |
| Revenue Next Year | $11.13 | $14.21 |
| P/E Ratio | $24.75 | ★ $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.66 | $36.14 |
| 52 Week High | $64.97 | $57.39 |
Technical Indicators
Market Signals| Indicator | EDU | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 36.76 |
| Support Level | $50.31 | N/A |
| Resistance Level | $54.82 | $42.19 |
| Average True Range (ATR) | 1.40 | 1.70 |
| MACD | -0.45 | -0.41 |
| Stochastic Oscillator | 33.72 | 3.79 |
Price Performance
Historical ComparisonAbout EDU New Oriental Education & Technology Group Inc.
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.